These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24339712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
    Jensen PE, Sellebjerg F, Søndergaard HB, Sørensen PS.
    Eur J Neurol; 2012 Oct; 19(10):1311-7. PubMed ID: 22564111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
    Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R, Malucchi S, Mehling M, Montalban X, Polman CH, Rudzki D, Schautzer F, Sellebjerg F, Sørensen PS, Deisenhammer F.
    Mult Scler; 2014 Apr; 20(5):577-87. PubMed ID: 24009164
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.
    Pachner AR, Warth JD, Pace A, Goelz S, INSIGHT investigators.
    Neurology; 2009 Nov 03; 73(18):1493-500. PubMed ID: 19884577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.
    Bertolotto A, Gilli F, Sala A, Capobianco M, Malucchi S, Milano E, Melis F, Marnetto F, Lindberg RL, Bottero R, Di Sapio A, Giordana MT.
    Neurology; 2003 Feb 25; 60(4):634-9. PubMed ID: 12601105
    [Abstract] [Full Text] [Related]

  • 12. Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations.
    Bertolotto A, Malucchi S, Milano E, Castello A, Capobianco M, Mutani R.
    Immunopharmacology; 2000 Jul 20; 48(2):95-100. PubMed ID: 10936507
    [Abstract] [Full Text] [Related]

  • 13. The clinical impact of interferon beta antibodies in relapsing-remitting MS.
    Perini P, Calabrese M, Biasi G, Gallo P.
    J Neurol; 2004 Mar 20; 251(3):305-9. PubMed ID: 15015010
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis.
    Gilli F, Hoffmann F, Sala A, Marnetto F, Caldano M, Valentino P, Kappos L, Bertolotto A, Lindberg RL.
    Mult Scler; 2006 Dec 20; 12(6):738-46. PubMed ID: 17263001
    [Abstract] [Full Text] [Related]

  • 16. Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patients.
    Sato DK, Nakashima I, Fukazawa T, Shimizu Y, Tomizawa Y, Yokoyama K, Misu T, Creeke PI, Farrell R, Giovannoni G, Itoyama Y, Fujihara K, Aoki M.
    Tohoku J Exp Med; 2012 Oct 20; 228(2):85-92. PubMed ID: 22976494
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
    Sorensen PS, Koch-Henriksen N, Ross C, Clemmesen KM, Bendtzen K, Danish Multiple Sclerosis Study Group.
    Neurology; 2005 Jul 12; 65(1):33-9. PubMed ID: 15888603
    [Abstract] [Full Text] [Related]

  • 20. The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
    Giantzi V, Karapanayiotides T, Lagoudaki R, Poulatsidou KN, Lourbopoulos A, Daniilidis M, Taskos N, Milonas I, Grigoriadis N.
    Eur Neurol; 2016 Jul 12; 75(1-2):82-8. PubMed ID: 26867030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.